Library 02 / The Asian Indian Phenotype

Why the Indian body ages differently.

The science that applies to European bodies does not apply, unchanged, to Indian bodies. Here's what changes for the Indian phenotype — and why it matters for how we age.

The science of aging that has been published in the last decade — the breakthroughs in longevity research, the protocols for healthspan extension, the understanding of how to slow biological aging — has been written almost entirely for European populations. The bodies studied in the most rigorous clinical trials are mostly white, mostly affluent, mostly from North America and Western Europe.

This is a problem. Not because other populations cannot benefit from this science — they can. But because applying that science unchanged to Asian Indian bodies is to ignore the biological, metabolic, and genetic differences that shape how Indians live and age.

This is not cultural commentary. This is genetics, metabolic physiology, and epidemiology.

The Asian Indian Phenotype

Thrifty Metabolism: Asian Indians show higher insulin resistance at lower body mass indexes. A BMI of 25 for an Indian is metabolically equivalent to a BMI of 27-28 for a European. This means the standard cut-offs for metabolic health do not apply. Standard protocols for diabetes prevention must be recalibrated.
Higher Cardiometabolic Risk: Indians have higher rates of cardiovascular disease and type 2 diabetes at younger ages and lower obesity levels than other populations. The "Asian Indian Paradox" — cardiovascular disease without obesity — is real and measurable. Our risk thresholds must be different.
Genetic Predisposition to Early Hypertension: Indian populations show earlier onset of hypertension (often by the 4th decade), independent of BMI or salt intake. Blood pressure targets and screening protocols must begin earlier.
Different Lipid Profiles: The lipid particle distribution in Asian Indians differs from European populations. Standard cholesterol measures (total cholesterol, LDL, HDL) are less predictive. Lipoprotein(a) and apolipoprotein B are more relevant markers of cardiovascular risk.
Genetic Variance in Drug Metabolism: Common medications — statins, beta-blockers, anticoagulants — are metabolized differently due to variations in cytochrome P450 enzymes that are more common in Indian populations. Standard dosing often produces suboptimal or adverse effects.
Nutritional and Micronutrient Deficiencies: Vegetarian diets prevalent in Indian populations require different approaches to B12, iron, and amino acid adequacy. Vitamin D deficiency is structural due to skin pigmentation and latitude. Supplementation protocols cannot be generic.

Protocol Recalibration

Standard longevity science is not wrong. But it is incomplete for Indian bodies. Every protocol published by this Institute — on cardiovascular health, metabolic disease prevention, longevity optimization — is recalibrated for the Asian Indian phenotype.

This is what "Indian First" means scientifically.

Institute
Research
Connect

Longevity Institute India

An independent research institute studying healthspan and lifespan in the South Asian context. Founded by Dr. Deepika Krishna. Open work. Open data. Free, forever.

© MMXXVI
NEW DELHI · VOL. 01
SET IN FRAUNCES & NEWSREADER
DISCLAIMER · PRIVACY · TERMS · EDITORIAL STANDARDS